Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
81.98
+0.57 (0.70%)
At close: Jul 28, 2025, 4:00 PM
82.46
+0.52 (0.63%)
Pre-market: Jul 29, 2025, 4:30 AM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.89 billion as of July 28, 2025. Its market cap has increased by 16.93% in one year.
Market Cap
5.89B
Enterprise Value
4.81B
1-Year Change
16.93%
Ranking
Category
Stock Price
$81.98
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.89B, an increase of 639.59%. That is a compound annual growth rate of 64.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 5.88B | 5.79% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.47B |
| Johnson & Johnson | 400.31B |
| AbbVie | 333.00B |
| Novo Nordisk | 311.87B |
| UnitedHealth Group | 255.92B |
| Novartis AG | 225.40B |
| AstraZeneca | 224.29B |
| Abbott Laboratories | 219.83B |